Literature DB >> 8764839

RB [corrected] as a modulator of transcription.

W R Sellers1, W G Kaelin.   

Abstract

pRB interacts with a number of transcription factors and can both directly and indirectly modulate transcriptional activity. Growth suppression by pRB is tightly linked to its ability to form complexes with E2F which are capable of repressing transcription of certain genes required for S phase. The ability of pRB to enhance the activity of several non-E2F transcription factors might suggest a mechanism by which pRB could coordinately regulate sets of genes at or near the restriction point. Specifically, complexes consisting of underphosphorylated pRB and E2F, by virtue of transcriptional repression of promoters containing E2F sites, would act to block entry into S phase. At the same time, distinct complexes of underphosphorylated pRB and transcription factors such as the glucocorticoid receptor, ATF-2, or MyoD, might lead to an increase in the transcription of genes required for differentiation or for additional growth inhibitory functions (e.g. TGF-beta 1). Changes in the activities of various cyclin-dependent kinase complexes would lead to phosphorylation of pRB and thus coordinate a release of S phase genes from repression with a loss of activation of differentiation genes. While this model is speculative, the role of pRB as a transcriptional modulator, as well as its interactions with cell-cycle regulatory kinases, places it in a position to integrate extracellular and intracellular growth signals and to transduce those signals into changes in gene transcription which ultimately influence cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764839     DOI: 10.1016/0304-419x(96)00014-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Cell cycle checkpoints as therapeutic targets.

Authors:  Z A Stewart; J A Pietenpol
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

2.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.

Authors:  L L Whitaker; H Su; R Baskaran; E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  Adenovirus E1A-regulated transcription factor p120E4F inhibits cell growth and induces the stabilization of the cdk inhibitor p21WAF1.

Authors:  E R Fernandes; J Y Zhang; R J Rooney
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

6.  Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.

Authors:  J Q Zhao; R M Glasspool; S F Hoare; A Bilsland; I Szatmari; W N Keith
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

7.  HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue.

Authors:  H H Shih; M Xiu; S P Berasi; E M Sampson; A Leiter; K E Paulson; A S Yee
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest.

Authors:  Xianmin Xia; Aiwu Cheng; Damilola Akinmade; Anne W Hamburger
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 9.  Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage.

Authors:  Louis L Sarliève; Angeles Rodríguez-Peña; Keith Langley
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

10.  Regulation of exit from quiescence by p27 and cyclin D1-CDK4.

Authors:  M H Ladha; K Y Lee; T M Upton; M F Reed; M E Ewen
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.